510(k) Report

510(k) · Cleared

Cleared

Silk Voice (SMI-04)

K240919510(k) SpecialCleared May 3, 202430-day reviewClass II21 CFR 874.3620

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sofregen Medical · MIX System, Vocal Cord Medialization

Cleared on May 3, 2024 as substantially equivalent to K180631 (Sofregen Medical, Inc., 2018) after a 30-day review. Its family tree reaches back 9 generations to 1992.

Decided
May 3, 2024
Review
30 days
Class
Class II
Product code
MIX
Recalls
None
Predicates
1

Its longest line of descent runs back 9 generations to K913882 (1992). 27 ancestors in all, the oldest K852682 (1985). No later device cites it as a predicate yet.

  1. Root · 9 generations backK913882 Zara Silicone BlockByron Medical · 1992
  2. 5 generations between
  3. 3 generations backK060815 Juliesse Injectable Laryngeal Augmentation ImplantBioform Medical, Inc. · 2006 · Recalled
  4. 2 generations backK070090 Radiesse Laryngeal ImplantBioform Medical, Inc. · 2007
  5. 1 generation backK180631 Silk VoiceSofregen Medical, Inc. · 2018
  6. This deviceK240919 Silk Voice (SMI-04)Sofregen Medical · 2024
Show all 9 generations
  1. Root · 9 generations backK913882 Zara Silicone BlockByron Medical · 1992
  2. 8 generations backK970910 Xomed Silicone Block/StripXomed, Inc. · 1997
  3. 7 generations backK972317 Montgomery Thyroplasty Implant SystemBoston Medical Products, Inc. · 1997
  4. 6 generations backK982294 Xomed Silicone Pre-Form BlocksXomed, Inc. · 1998
  5. 5 generations backK013243 Coaptite Laryngeal Augmentation System 1CC & O.5CC, Models…Bioform, Inc. · 2002 · Recalled
  6. 4 generations backK033398 Laryngeal Augmentation ImplantBioform, Inc. · 2003
  7. 3 generations backK060815 Juliesse Injectable Laryngeal Augmentation ImplantBioform Medical, Inc. · 2006 · Recalled
  8. 2 generations backK070090 Radiesse Laryngeal ImplantBioform Medical, Inc. · 2007
  9. 1 generation backK180631 Silk VoiceSofregen Medical, Inc. · 2018
  10. This deviceK240919 Silk Voice (SMI-04)Sofregen Medical · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K913882Zara Silicone BlockByron Medical1992—
−8K970910Xomed Silicone Block/StripXomed, Inc.1997—
−7K972317Montgomery Thyroplasty Implant SystemBoston Medical Products, Inc.1997—
−6K982294Xomed Silicone Pre-Form BlocksXomed, Inc.1998—
−5K013243Coaptite Laryngeal Augmentation System 1CC & O.5CC, Models 0008021-1, 0008022-1Bioform, Inc.20021
−4K033398Laryngeal Augmentation ImplantBioform, Inc.2003—
−3K060815Juliesse Injectable Laryngeal Augmentation ImplantBioform Medical, Inc.20061
−2K070090Radiesse Laryngeal ImplantBioform Medical, Inc.2007—
−1K180631Silk VoiceSofregen Medical, Inc.2018—
0 (this device)K240919Silk Voice (SMI-04)Sofregen Medical2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198530
198610
199110
199210
199410
199520
199630
199830
199910
200010
200310
FIG. 1 — Lineage of K240919, 1992–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MIX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K180631Silk Voice
Summary page 4
…n Regulation: 21 CFR 874.3620 Regulatory Class: II Product Code: MIX Panel: Ear, Nose, and Throat 3. PREDICATE DEVICE Predicate Device: Sofregen’s Silk Voice (K180631) 4. DEVICE DESCRIPTION Silk Voice® is a sterile, non-pyrogenic, cohesive implant provided in a prefilled syringe and i…
Sofregen Medical, Inc.2018—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 32 years and passes through 7 companies; a new generation was cleared every 2.3 years on median.
  • 2 of the 27 ancestors have a recall of any class.

How does its category compare?

All MIX devices

MIX System, Vocal Cord Medialization: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · MIX

1in 2024

2007: 12008: 22009: 32013: 12015: 12018: 12024: 1
2007high 3 (2009) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MIX

193in 2009

2009: 193 days median
2007high 193 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MIX

1in 2015

2015: 1
2007high 1 (2015) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MIX

2in 2024

2009: 22010: 22012: 22014: 12015: 12016: 12017: 32018: 52019: 12020: 102021: 52023: 42024: 2
2007high 10 (2020) · low 0 (2007)2025

MAUDE reports naming product code MIX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—00
2009319302
20100—02
20110—00
20120—02
20131—00
20140—01
20151—11
20160—01
20170—03
20181—05
20190—01
20200—010
20210—05
20220—00
20230—04
20241—02
20250—00
20260—0—

What is it indicated for?

Silk Voice® is indicated for vocal fold medialization and vocal fold insufficiency that may be improved by injection of a soft tissue bulking agent. Silk Voice® injection augments the size of the displaced or deformed vocal fold so that it may meet the opposing fold at the midline for improved phonation. Vocal fold insufficiency associated with serious aspiration difficulties may be an urgent indication.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K240919: Silk Voice (SMI-04).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K240919

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026